000 | 01580 a2200457 4500 | ||
---|---|---|---|
005 | 20250511221227.0 | ||
264 | 0 | _c19910731 | |
008 | 199107s 0 0 eng d | ||
022 | _a0031-4005 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPhibbs, R H | |
245 | 0 | 0 |
_aInitial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. _h[electronic resource] |
260 |
_bPediatrics _cJul 1991 |
||
300 |
_a1-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aBirth Weight |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 |
_aFatty Alcohols _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyaline Membrane Disease _xdrug therapy |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aPhosphorylcholine |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 |
_aPulmonary Surfactants _xadministration & dosage |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aRespiration, Artificial |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aBallard, R A | |
700 | 1 | _aClements, J A | |
700 | 1 | _aHeilbron, D C | |
700 | 1 | _aPhibbs, C S | |
700 | 1 | _aSchlueter, M A | |
700 | 1 | _aSniderman, S H | |
700 | 1 | _aTooley, W H | |
700 | 1 | _aWakeley, A | |
773 | 0 |
_tPediatrics _gvol. 88 _gno. 1 _gp. 1-9 |
|
999 |
_c2063396 _d2063396 |